[1]廖晓星,侯 垒,于洪远,等.北京丰台地区导尿管相关性尿路感染病原菌分布及耐药分析[J].新乡医学院学报,2017,34(4):286-289.[doi:10.7683/xxyxyxb.2017.04.010]
 LIAO Xiao-xing,HOU Lei,YU Hong-yuan,et al.Distribution and drug resistance of pathogenic bacterium in patients with catheter associated urinary tract infection in Fengtai district of Beijing city[J].Journal of Xinxiang Medical University,2017,34(4):286-289.[doi:10.7683/xxyxyxb.2017.04.010]
点击复制

北京丰台地区导尿管相关性尿路感染病原菌分布及耐药分析
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年4
页码:
286-289
栏目:
临床研究
出版日期:
2017-04-05

文章信息/Info

Title:
Distribution and drug resistance of pathogenic bacterium in patients with catheter associated urinary tract infection in Fengtai district of Beijing city
作者:
廖晓星1侯 垒1于洪远2徐 婷2崔功静1杨江华1马伟立1
(1.北京航天总医院泌尿外科,北京 100076;2.北京航天总医院检验科,北京 100076)
Author(s):
LIAO Xiao-xing1HOU Lei1YU Hong-yuan2XU Ting2CUI Gong-jing1YANG Jiang-hua1MA Wei-li1
(1.Department of Urology,Beijing Aerospace General Hospital,Beijing 100076,China;2.Department of Clinical Laboratory,Beijing Aerospace General Hospital,Beijing 100076,China)
关键词:
导尿管相关性尿路感染病原菌耐药性
Keywords:
catheter associated urinary tract infectionpathogenic bacteriadrug resistance
分类号:
R446.5
DOI:
10.7683/xxyxyxb.2017.04.010
文献标志码:
A
摘要:
目的 了解北京丰台地区导尿管相关性尿路感染(CAUTI)患者的病原菌分布及耐药特点,为临床抗菌药物选择提供依据。方法 对2014年1月至2015年12月北京丰台区东高地社区医院、万源路社区医院、东营房社区医院及北京航天总医院239例CAUTI患者进行尿培养及药物敏感性试验,统计分析病原菌特点及耐药情况。结果 239例尿路感染患者标本培养出255株病原菌,其中革兰阴性菌141株(55.3%),革兰阳性菌44(17.3%),真菌70株(27.5%);革兰阴性菌以大肠埃希菌为主(73/255,28.6%),革兰阳性菌以肠球菌为主(17/255,6.7%),真菌以白色念珠菌为主(55/255,21.6%)。大肠埃希菌、白色念珠菌、屎肠球菌检出病例中,2015年所占比例均高于2014年。主要革兰阴性菌大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌对氨苄西林、头孢唑林、氨苄西林/舒巴坦、环丙沙星的耐药率均>60.00%,对亚胺培南、美洛配能的耐药率均<8.33%;主要革兰阳性菌屎肠球菌、葡萄球菌对克林霉素、头孢西丁、妥布霉素、甲氧苄啶、庆大霉素、复方新诺明、苯唑西林、阿米卡星的耐药率均>75.00%,对利奈唑胺的耐药率<5.88%,对替考拉宁、万古霉素的耐药率均为0.00%。结论 CAUTI主要致病菌为革兰阴性菌,并有较多的条件致病菌如真菌及革兰阳性菌,致病菌耐药现状严重,应注意减少感染的发生,并严格遵循药物敏感性试验结果指导临床用药。
Abstract:
Objective To investigate the distribution and drug resistance of pathogenic bacterium in patients with catheter associated urinary tract infection(CAUTI) in Fengtai district of Beijing city;and provide the evidence for the selection of clinical antibacterials.Methods A total of 239 cases of CAUTI were performed with urine culture and drug sensitive test in Donggaodi Community Hospital,Wanyuan Road Community Hospital,Dongyingfang Community Hospital and Beijing Aerospace General Hospital from January 2014 to December 2015.Characteristics and drug resistance of pathogenic bacterium were analyzed.Results A total of 255 strains of pathogenic bacterium were isolated from the specimens of 239 patients with CAUTI,including 141(55.3%) strains of Gram-negative bacterium,44(17.3%) strains of Gram-positive bacterium and 70(27.5%) strains of fungus.The main Gram-negative bacterium,Gram-positive bacterium and fungus was Escherichia coli(73/255,28.6%),Enterococcus(17/255,6.7%) and Candida albicans(55/255,21.6%) respectively.The proportion the cases of Escherichia coli,Candida albicans and Enterococcus faecium in 2015 was higher than that in 2014.The drug resistance rate of main Gram-negative bactria(Escherichia coli,Klebsiella pneumoniae and Pseudomonas aeruginosa) to ampicillin,cefazolin,ampicillin/sulbactam and ciprofloxacin was more than 60.00%;and the drug resistance rate of them to imipenem and meropenem less than 8.33%.The drug resistance rate of main Gram-positive bacterium(Enterococcus faecium and Staphylococcus aureus) to clindamycin,cefoxitin,tobramycin,gentamicin,trimethoprim,sulfamethoxazole,oxacillin and amikacin was more than 75.00%;the drug resistance rate of them to linezolid less than 5.88%,and the drug resistance rate of them to teicoplanin and vancomycin was 0.00%.Conclusion The main pathogenic bacteria of CAUTI is Gram-negative bacteria,and there are more opportunistic pathogens such as fungi and Gram-positive bacteria.The drug resistance of pathogenic bacteria is serious,we should pay attention to reduce the incidence of infection,and strictly follow the drug sensitivity results to guide clinical medication.

参考文献/References:

[1] REGAGNIN D A,DA SILVA ALVES D S,MARIA CAVALHEIRO A,et al.Sustainability of a program for continuous reduction of catheter-associated urinary tract infection[J].Am J Infect Control,2016,44(6):642-646.
[2] MEDDINGS J,SAINT S,MCMAHON L F J R.Hospital-acquired catheter-associated urinary tract infection:documentation and coding issues may reduce financial impact of Medicare′s new payment policy[J].Infect Control Hosp Epidemiol,2010,31(6):627-633.
[3] 尚红,王毓三,申子瑜.全国临床检验操作规程[M].4版.北京:人民卫生出版社,2015:634-636.
[4] CLSI/CLINICAL AND LABORATORY STANDARD INSTITUTE.Performance standards for antimicrobials susceptibility testing;twenty-first informational supplement[S].M100-S23.2013.
[5] AL-QAS HANNA F,SAMBIRSKA O,IYER S,et al.Clinician practice and the National Healthcare Safety Network definition for the diagnosis of catheter-associated urinary tract infection[J].Am J Infect Control,2013,41(12):1173-1177.
[6] LASSEK C,BURGHARTZ M,CHAVES-MORENO D,et al.A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections(CAUTIs)[J].Mol Cell Proteomics,2015,14(4):989-1008.
[7] 孙一奎,张传领,赵枫,等.尿路感染患者病原菌分布及耐药性监测[J].中华医院感染学杂志,2014,24(2):314-315.
[8] ROSENTHAL V D,TODI S K,ALVAREZ-MORENO C,et al.Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries:findings of the International Nosocomial Infection Control Consortium(INICC)[J].Infection,2012,40(5):517-526.
[9] 纪翠芳,鲁琼,肖轶雯,等.导尿管相关性尿路感染病原菌分布和耐药性及治疗[J].中国医院药学杂志,2013,33(22):1897-1900.
[10] 邓乃梅,郑军,王虹.重症监护病房导管相关性真菌感染患者调查[J].中国医院统计,2013,20(4):319-320.
[11] 姚燕,胡昌弟,李小青,等.ICU留置导尿患者尿培养病原菌分布与耐药性[J].中华医院感染学杂志,2015,25(1):64-66.
[12] 王拥涛,周晨妍,付君静,等.医院住院患者泌尿系感染病原菌分布及耐药性分析[J].新乡医学院学报,2016,33(6):497-499.
[13] GIRI S,KINDO A J,KALYANI J.Candidemia in intensive care unit patients:a one year study from a tertiary care center in South India[J].J Postgrad Med,2013,59(3):190-195.
[14] 邵俊,郑瑞强,林华,等.ICU导尿管相关性尿路感染的病原菌分布及耐药性分析[J].医学理论与实践,2013,26(22):2941-2942.
[15] 程晓玲,黄宏耀,程伟,等.神经内科患者导尿管相关性尿路感染病原菌的耐药性分析[J].中华医院感染学杂志,2013,23(22):5597-5598.

相似文献/References:

[1]王宝风.新生儿呼吸机相关肺炎的病原学分析[J].新乡医学院学报,2001,18(04):291.
[2]郭珊,李瑞.46株耐药谱相同菌所致医院感染与耐药性分析 [J].新乡医学院学报,2004,21(02):000.
[3]何群力,杨帆,李淑梅,等.医院内病原菌的分离及耐药性研究 [J].新乡医学院学报,2007,24(04):340.
[4]褚月娇,韩莹莹,黄婷婷,等.老年与中青年患者产超广谱β-内酰胺酶肺炎克雷伯菌的分布及耐药性对比分析[J].新乡医学院学报,2017,34(9):803.[doi:10.7683/xxyxyxb.2017.09.006]
 CHU Yue-jiao,HAN Ying-ying,HUANG Ting-ting,et al.Comparative analysis of distribution and drug resistance of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in elderly and young and middle-aged patients[J].Journal of Xinxiang Medical University,2017,34(4):803.[doi:10.7683/xxyxyxb.2017.09.006]
[5]王 娟,李 凯,王勇兵,等.革兰阴性菌血流感染患儿临床特点及病原菌分布和耐药性分析[J].新乡医学院学报,2019,36(7):634.[doi:10.7683/xxyxyxb.2019.07.008]
 WANG Juan,LI Kai,WANG Yong-bing,et al.Clinical characteristics,pathogenic bacteria distribution and drug resistance of children with gram-negative bacterial bloodstream infection[J].Journal of Xinxiang Medical University,2019,36(4):634.[doi:10.7683/xxyxyxb.2019.07.008]
[6]王 艳.儿童血流感染病原菌分布及耐药性分析[J].新乡医学院学报,2021,38(6):559.[doi:10.7683/xxyxyxb.2021.06.013]
 WANG Yan.Distribution and drug resistance of pathogenic bacteria of children with bloodstream infection[J].Journal of Xinxiang Medical University,2021,38(4):559.[doi:10.7683/xxyxyxb.2021.06.013]
[7]朱 萍,李德亮,张伟业.下呼吸道感染新生儿多重耐药菌感染及影响因素分析[J].新乡医学院学报,2020,37(7):670.[doi:10.7683/xxyxyxb.2020.07.017]
 ZHU Ping,LI Deliang,ZHANG Weiye.Analysis of multidrug-resistant bacteria infection and its influencing factors in neonates with lower respiratory infection[J].Journal of Xinxiang Medical University,2020,37(4):670.[doi:10.7683/xxyxyxb.2020.07.017]
[8]韩 冬,张 超,杜守峰,等.冠状动脉旁路移植术后感染病原菌分布、耐药性及危险因素分析[J].新乡医学院学报,2020,37(8):773.[doi:10.7683/xxyxyxb.2020.08.017]
 HAN Dong,ZHANG Chao,DU Shoufeng,et al.Distribution characteristics and drug resistance of pathogenic bacteria and the risk factors of postoperative infection in patients underwent coronary artery bypass grafting[J].Journal of Xinxiang Medical University,2020,37(4):773.[doi:10.7683/xxyxyxb.2020.08.017]
[9]王 俊,文建国.儿童中枢神经系统感染脑脊液病原菌分布及耐药性分析[J].新乡医学院学报,2019,36(4):384.[doi:10.7683/xxyxyxb.2019.04.021]
 WANG Jun,WEN Jian-guo.Distribution and drug resistance of cerebrospinal fluid pathogens in children with central nervous system infection[J].Journal of Xinxiang Medical University,2019,36(4):384.[doi:10.7683/xxyxyxb.2019.04.021]
[10]邢彦峰,巨超龙.结直肠癌患者术后感染的危险因素及病原菌和耐药性分析[J].新乡医学院学报,2018,35(2):110.[doi:10.7683/xxyxyxb.2018.02.007]
 XING Yan-feng,JU Chao-long.Analysis of the risk factors,pathogenic bacteria and drug resistance of postoperative infection in patients with colorectal cancer[J].Journal of Xinxiang Medical University,2018,35(4):110.[doi:10.7683/xxyxyxb.2018.02.007]

更新日期/Last Update: 2017-04-05